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Altered pathways in methylome 
and transcriptome longitudinal 
analysis of normal weight and 
bariatric surgery women
c. f. nicoletti1, M. A. S. pinhel1,2, n. Y. noronha1, B. A. de oliveira1, W. Salgado Junior3A. Jácome4, 
A. Diaz-Lagares5,6, f. casanueva7,8, A. B. crujeiras  7,8*, & c. B. nonino1*
DnA methylation could provide a link between environmental, genetic factors and weight control and can 
modify gene expression pattern. This study aimed to identify genes, which are differentially expressed 
and methylated depending on adiposity state by evaluating normal weight women and obese women 
before and after bariatric surgery (BS). We enrolled 24 normal weight (BMI: 22.5 ± 1.6 kg/m2) and 24 obese 
women (BMI: 43.3 ± 5.7 kg/m2) submitted to BS. Genome-wide methylation analysis was conducted 
using Infinium Human Methylation 450 BeadChip (threshold for significant CpG sites based on delta 
methylation level with a minimum value of 5%, a false discovery rate correction (FDR) of q < 0.05 
was applied). Expression levels were measured using HumanHT-12v4 Expression BeadChip (cutoff of 
p ≤ 0.05 and fold change ≥2.0 was used to detect differentially expressed probes). The integrative 
analysis of both array data identified four genes (i.e. TPP2, PSMG6, ARL6IP1 and FAM49B) with higher 
methylation and lower expression level in pre-surgery women compared to normal weight women: and 
two genes (i.e. ZFP36L1 and USP32) that were differentially methylated after BS. These methylation 
changes were in promoter region and gene body. All genes are related to MAPK cascade, NIK/NF-
kappaB signaling, cellular response to insulin stimulus, proteolysis and others. integrating analysis 
of DnA methylation and gene expression evidenced that there is a set of genes relevant to obesity 
that changed after BS. A gene ontology analysis showed that these genes were enriched in biological 
functions related to adipogenesis, orexigenic, oxidative stress and insulin metabolism pathways. Also, 
our results suggest that although methylation plays a role in gene silencing, the majority of effects were 
not correlated.
DNA methylation in CpG dinucleotides is a dynamic process and best characterized epigenetic modifications1. 
Methylation patterns are established in early life and can be remodeled in adult cells, by modulating DNA inter-
actions with proteins and transcription factors2,3, being able to alter gene expression profile4.
Weight gain or loss during infancy and adulthood, by changing the energy storage and adipose tissue homeo-
stasis, may alter molecular mechanisms and biological processes5. In line of this, epigenetic changes may predis-
pose a disease risk or can occur once a disease has developed6. Thus, DNA methylation provides a link between 
environmental, genetic factors and weight control.
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Obesity has reached epidemic proportions and, in 2016, affected about 1.9 billion adults worldwide7, being 
associated to a public health burden. In the context of obesity treatment, bariatric surgery (BS) has been the best 
choice for cases of severe obesity and has been shown to be the most effective way to promote significant and 
sustained weight loss8. Among the surgical techniques, Roux-en-Y gastric bypass (RYGB) is the most performed 
in Brazil and worldwide, and is considered a gold standard because its high efficacy and low morbid-mortality9. 
However, inter-individual variability of the response to bariatric surgery, mainly related to weight loss, is evi-
dent10, and the unpredictability of weight-loss success represents a significant barrier in the surgical management 
of obesity11.
Recent epigenome-wide association studies (EWAS) evidenced multiple DNA methylation loci associated 
with body mass index (BMI)12,13. In addition, the role of epigenetic signature in metabolic results after obesity 
treatment has been described previously14,15. Knowing that nutrition is one of the greatest environmental stimuli 
that can change gene methylation/expression signature16, some studies have demonstrated that BS changes DNA 
methylation levels17. Other publications have evidenced that weight loss by surgery is also able to modify gene 
expression levels, mainly of genes related to metabolic pathways18,19.
The relevance of differential DNA methylation and gene expression consequent of BS was previously evi-
denced by our research group20,21; however, to gain a broader perspective about the interface between CpG 
methylation and functional effects in transcription, we performed an integrated analysis with methylation and 
expression data. Thus, the objective of the current study was to identify genes, which are differentially expressed 
and methylated depending on adiposity state by evaluating normal weight women and obese women before and 
after BS.
Results
Sample characteristics. No significant difference was found between the ages of each group (obese patients: 
36.9 ± 10.2 years and normal weight women: 36.9 ± 11.8 years; p > 0.05). Normal weight women showed a mean 
weight of 60.7 ± 6.3 kg and mean fat mass of 29.6 ± 4.1%. After 6 months of BS, we evidenced a significant weight 
(113.3 ± 16.3 to 86.3 ± 12.5 kg, p < 0.001), BMI (43.3 ± 5.7 to 33.1 ± 4.8 kg/m2, p < 0.001) and fat mass (45.7 ± 5.7 
to 36.1 ± 5.9%, p < 0.001) reduction.
comparison of gene expression and methylation patterns and integrated analysis of the 
data. From the genome-wide DNA methylation study, 1,074 CpG sites (located in 769 genes) were differ-
entially methylated between obese women before BS and normal weight women, and most of them showed 
high methylation level in obese patients. Also, 666 CpGs (located in 495 genes) had methylation levels changed 
after RYGB. For the microarray gene expression analysis, a total of 600 genes were differently expressed (DEGs) 
between obese women before BS and normal weight patients. Indeed, 1,366 genes were differentially expressed 
between surgery times. Among these, 88 genes were up- and 512 genes were down-regulated.
Figure 1 illustrates the Venn diagram showing the overlap of differently expressed genes (fold change >2, 
FDR p < 0.05) and differently methylated CpG sites (Δβ ± 5%, p < 0.001). When preoperative patients and 
normal weight women were compared, a total of six genes were, concomitantly, differentially methylated and 
expressed (Fig. 1A). Two of them (CCNL1 and SLC5A8) present their methylation and expression levels in the 
same direction: both lower in preoperative patients compared to normal weight women. However, four genes 
(TPP2, PSMG6, ARL6IP1 and FAM49B) presented methylation and expression levels in opposite direction: higher 
methylation and lower expression level in pre-surgery women compared to normal weight women. Also, these 
CpG sites were located at TSS200, TSS1500 and 5′UTR regions (gene promoter region).
Considering pre and postoperative times comparison, Venn diagram analysis identified a total of eight genes 
that were common in methylation and expression arrays (Fig. 1B). Of these, two genes (ZFP36L1 and USP32) 
were differentially methylated and expressed after RYGB. Methylation and expression levels of ZFP36L1 and 
USP32 genes were changed in opposite direction. For ZFP36L1, the methylation level decreased after surgery 
while its expression increased. In contrast, for USP32, methylation level increased and expression decreased after 
the surgery. Considering CpGs location, we observed that they were located in gene body and TSS1500 region.
The expression analysis between postoperative and normal weight individuals showed no differential gene 
expression, thus concomitant analysis between methylation and expression profile couldn’t be performed.
Table 1 summarizes the results of integrated analysis between DNA methylation and gene expression arrays, 
that is, gene concomitantly differently methylated and expressed between groups (obese and normal weight 
women) and periods (before and after BS).
To additional understanding about the biological relevance of the identified genes, GO analyses were per-
formed. These analyses showed that these genes are related to MAPK cascade, NIK/NF-kappaB signaling, cellular 
response to insulin stimulus, proteolysis and others.
Discussion
We identified in the present study genes that are concomitant differentially methylated and expressed in leuko-
cytes after BS. Relevantly, these genes were involved in molecular pathways related to obesity´s physiopathology. 
Also, comparing obese subjects (before BS) and normal weight women, we identified four genes that showed 
lower expression and higher methylation levels; which were related to adipogenesis, anti-satiety effect, oxidative 
stress, and insulin metabolism. Moreover, we evidenced that two genes related to proteolysis and adipogenesis, 
were epigenetically regulated by RYGB procedure.
Despite the fact that the impact of DNA methylation on gene expression seems to depend of cytosine meth-
ylated site and location22,23, results obtained here showed that promoter methylation (TSS200 and TSS1500) is 
associated with decreased expression; however, for specific CpG sites, intragenic methylation (gene body) also 
correlates with decreased gene expression. Grundberg et al.24, found that a large number of methylation and 
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expression associations were positive, thus the increase in methylation levels was linked to an increase of corre-
sponding gene expression. More interestingly, evidence suggested there an adjustment mechanism of body gene 
methylation levels for transcription regulation. In line of this, when promoter methylation is constant, increasing 
body methylation is associated with more repressed expression25. Thus, considering that some authors affirmed 
that the function of DNA methylation in intergenic and gene-body regions is less defined24, our results showed 
that regardless of the location of methylated cytosine (promoter region or body), DNA methylation promotes a 
reduction in gene expression.
In addition, it is important to highlight that the expression of two (CCNL1 and SLC5A8) and six genes 
(MED21, CD302, CLEC12B, MNAT1, CHD6 and CCNH) were not regulated by DNA methylation in obese versus 
normal weight and preoperative versus postoperative comparisons, respectively. Study with cancer cells showed 
that the presence of methylation does not always imply in gene silencing26. Thus, our results showed that despite 
methylation plays a role in gene silencing, the majority of effects were not correlated.
Another point to be discussed is that the present study is the first to identify an association between TPP2, 
PSMC6, ARL6IP1 and FAM49B genes with obesity. The TPP2 gene codifies a peptidase that has been related to an 
anti-satiety effect by degrading the cholecystokinin 8 hormone (CCK8) and adipogenesis stimulus, pointing to 
an important role of TPP2 in obesity27,28. Thus, TPP2 seems to have dual role in metabolic homoeostasis, affecting 
both feeding behavior and adipose tissue biology per se28. Moreover, TPP2 is also related to different isoforms of 
protein convertase gene family (PSCK) that are associated with obesity related traits (e.g PCSK1 and PCSK2)29.
On the other hand, ARL6IP1 and PSMC6 have been associated with insulin synthesis and pathology of diabe-
tes, respectively30,31. Also, ARL6IP1 protein is associated phosphatidylethanolamine-binding family of proteins 
(PEBP1), which has important role in MAPK, NF-kappa B, and glycogen synthase kinase-3 (GSK-3) signaling 
pathways. PSMC6 gene encodes one of the ATPase subunits and its expression was inversely correlated with 
BMI11.
Lastly, FAM49B has been appointed as novel regulator of mitochondrial function and may thus be associated 
with oxidative stress and inflammation, however, up to now, no functional data about this protein has been pub-
lished32. Furthermore, USP32 is a highly conserved gene and uncharacterized gene that its stable silencing caused 
a significant decrease in the proliferation and migration rate of cells9. For this reason, USP32 has been associated 
with growth rate of cancer cells9,33.
We also identified that bariatric surgery modify ZFP36L1 and USP32 methylation and expression levels in leu-
kocytes. In culture 3T3-L1 preadipocytes, ZFP36L1 was associated with adipogenesis34 by regulating adipogenesis 
rate, playing an important role in obesity development35. According to Tseng36, ZFP36L1 overexpression might 
repress adipogenesis at least by down-regulating PPARG2 expression. These findings are a proof that blood leu-
kocytes are able to reflect the regulation of same adipose tissue biology-related genes as it was also demonstrated 
in previous reports13,37–39. In the current research, we were unable to detect differences in methylation levels of 
previously identified obesity related CpG sites, probably because differences in the study design, sample size or 
the threshold used for selection of candidates. However, the current study adds new information to this issue. In 
Figure 1. Clustering analysis of the methylation and expression arrays. (A) Venn diagram of genes detected in 
the pre-surgery versus the normal weight patients; (B) Venn diagram of genes detected in pre-surgery period 
versus the post-surgery period.
4Scientific RepoRtS |         (2020) 10:6515  | https://doi.org/10.1038/s41598-020-60814-9
www.nature.com/scientificreportswww.nature.com/scientificreports/
fact, the identified genes were involved in adipose tissue-related pathways that were also observed in previous 
reports on obesity-related methylation profile13,38,39.
The use of DNA and RNA extracted from leukocytes is a limitation of this study because both, expression 
and methylation, are tissue specific molecular mechanisms. However, leukocytes samples are less invasive, more 
convenient and acceptable than biopsies of target tissues (i.e adipose tissue) to perform longitudinal assessments 
and more suitable in clinical practice. To search for obesity-associated epigenetic biomarkers for the diagnosis 
and management of the disease is a huge challenge as adipose tissue is inaccessible without surgery. As mentioned 
above, in the obesity field, relevant studies have been recently published providing evidence that blood cells can 
be used to identify robust and biologically relevant epigenetic variation related to BMI. Moreover, it was demon-
strated that epigenetic biomarkers in blood could mirror age-related epigenetic signatures in biologically rele-
vant target tissues such as adipose tissue. Therefore, blood leukocytes are suitable, minimally invasive biological 
sources to evaluate obesity signatures. On the other hand, even though the identified changes in methylation and 
expression pattern induced by bariatric surgery in the present study could be transient, long-term studies would 
indicate the degree of plasticity of the epigenomic changes associated with bariatric surgery and would establish 
if over a longer time, the methylation profiles returned to the obese-pre surgery levels.
Obese patients before bariatric surgery versus normal weight women
Gene
Fold change 
(OB-NW) CpG name CpG region Δβ (OB-NW) Integrated results Gene Ontology (by GOA)
TPP2 −0.42 cg02184819 PR 0.057 +methylated on obese−expressed on obese
proteolysis
protein polyubiquitination
PSMC6 −0.23 cg00686598 PR 0.094 +methylated on obese−expressed on obese
MAPK cascade
NIK/NF-kappaB signaling
ARL6IP1 −0.23 cg08040170 PR 0.076 +methylated on obese−expressed on obese
apoptotic process
cotranslational protein targeting to 
membrane
FAM49B −0.44 cg02711724 Body 0.107 +methylated on obese−expressed on obese
platelet degranulation
positive regulation of T cell activation
CCNL1 −0.30 cg02399570 Body −0.093 −methylated on obese−expressed on obese
positive regulation of cyclin-dependent 
protein serine/threonine kinase 
activity
SLC5A8 −0.49 cg06162589 Body −0.055 −methylated on obese−expressed on obese
NAD biosynthesis via nicotinamide 
riboside salvage pathway
short-chain fatty acid import
Before versus after bariatric surgery
Gene Symbol Fold change (OB-NW) CpG name CpG region Δβ (OB-NW) Integrated results Gene function (by GOA)
ZFP36L1 2.18 cg08169020 Body 0.077 −methylated after RYGB+expressed after RYGB
MAPK cascade
cellular response to insulin stimulus
USP32 0.40 cg00691729 Body 0.076 +methylated after RYGB−expressed after RYGB
protein deubiquitination
ubiquitin-dependent protein catabolic 
process
MED21 7.58 cg01982833 PR 0.074 +methylated after RYGB+expressed after RYGB
positive regulation of transcription by 
RNA polymerase II
stem cell population maintenance
CD302 3.25 cg03432176 PR 0.069 +methylated after RYGB+expressed after RYGB
phagocytosis
signal transduction
CLEC12B 4.19 cg05849676 Body 0.069 +methylated after RYGB+expressed after RYGB
negative regulation of signaling 
receptor activity
natural killer cell inhibitory signaling 
pathway
MNAT1 2.28 cg07212327 Body 0.055 +methylated after RYGB+expressed after RYGB
DNA repair
adult heart development
CHD6 2.14 cg00514723 PR 0.051 +methylated after RYGB+expressed after RYGB
positive regulation of transcription 
from RNA polymerase II promoter in 
response to oxidative stress
viral process
CCNH 2.18 cg02021919 Body 0.087 +methylated after RYGB+expressed after RYGB
protein phosphorylation
positive regulation of cyclin-dependent 
protein serine/threonine kinase 
activity
Table 1. Genes overrepresented identified from differential methylation and expression arrays. OB: obese 
women; NW: normal weight women; Methylation data showed in Δβ; Expression data showed in Fold change; 
GOA: Gene Ontology Annotation; TPP2: tripeptidyl peptidase 2; PSMC6: proteasome 26S subunit, ATPase 
6; ARL6IP1: ADP ribosylation factor like GTPase 6 interacting protein 1; FAM49B: family with sequence 
similarity 49 member B; CCNL1: cyclin L1; SLC5A8: solute carrier family 5 member 8; ZFP36L1: ZFP36 ring 
finger protein like 1; USP32: ubiquitin specific peptidase 32; MED21: mediator complex subunit 21; CD302: 
CD302 molecule; CLEC12B: C-type lectin domain family 12 member B; MNAT1: CDK activating kinase 
assembly fator; CHD6: chromodomain helicase DNA binding protein 6; CCNH: cyclin H; PR: promoter region 
(TSS200, TSS1500, 5′UTR). p < 0.001 for all analysis.
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In conclusion, integrating analysis of DNA methylation and gene expression evidenced that there is a set of 
genes relevant to obesity that changed after BS. A gene ontology analysis showed that these genes were enriched 
in biological functions related to adipogenesis, orexigenic, oxidative stress and insulin metabolism pathways. 
Also, our results suggest that although methylation plays a role in gene silencing, the majority of effects were not 
correlated.
Methods
Study participants. The present study included 24 normal weight women (BMI: 22.5 ± 1.6 kg/m2, 
36.9 ± 11.8 years) and 24 severe obese women (BMI: 43.3 ± 5.7 kg/m2, 36.9 ± 10.2 years) submitted to RYGB 
which methylation and gene expression profile had been analyzed previously20,21. All samples from obese women 
were collected at preoperative time and after 6 months of bariatric surgery. Normal weight women were evaluated 
once.
All obese participants underwent open performed RYGB surgery that consisted in creating a small gastric por-
tion (30 to 50 mL) and an anastomosis of the gastric stump to the jejunum (both remaining loops measured about 
100 cm). The surgical procedure was standardized at our hospital following the most usual pattern performed 
worldwide and well described40. There were not postoperative complications in the patients included in this study.
The study was conducted with the approval of the Hospital Ethics Committee and in agreement with the 
Declaration of Helsinki. Informed consent was obtained from all individual participants included in the study. 
All methods were carried out in accordance with relevant guidelines and regulations.
DnA methylation array analysis and data processing. As aforementioned21, genomic DNA was 
extracted from peripheral mononuclear blood cells (PMBC) using GE Health Care kit (Illustra blood genomic 
Prep Mini Spin kit) and this extracted DNA was stored at −80 °C until the next steps. DNA fragmentation or 
RNA contamination was analyzed by 1% agarose gel electrophoresis. Also, DNA was bisulfite converted using EZ 
DNA methylation kit Methylation-Gold (Zymo Research, CA, USA) according to the manufacturer’s instructions 
and then immediately hybridized in BeadChip. Genome-wide methylation analysis was conducted using the 
Infinium Human Methylation 450 BeadChip (Illumina, San Diego, CA, USA). Beadchips were scanned with the 
Illumina iScanSQ system and DNA quality checks, bisulfite modification, hybridization, data normalization, and 
statistical filter were performed as described before21.
Analysis of methylation data were conducted using the Genome Studio software version 2011.1 (Illumina 
Inc.) and methylation levels were expressed in beta values (β). β values that were calculated as the intensity of the 
methylated channel divided by the total intensity (β = Max (SignalB, 0)/(Max (SignalA, 0) + Max (SignalB, 0) 
+ 100), and ranged from 0 (unmethylated) to 1 (fully methylated). β values with detection p-values > 0.01 were 
removed from analysis because were considered to fall below the minimum intensity and threshold. Also, probes 
that were localized to the sex chromosomes and those CpGs that contained single nucleotide polymorphisms 
were filtered out.
Differences in methylation levels between preoperative and postoperative groups (Δβ) was calculated for a 
given CpG site by subtracting the mean beta value from the pool of pre-surgery samples (pre-surgery period) as 
compared to the pool of samples collected after six months of RYGB and were tested by t test. Values of p were 
adjusted for multiple comparisons by using the false discovery rate (FDR below 5% was considered statistically 
significant). Also, a threshold for the significant CpG sites based on Δβ with a minimum value of 5% (value 
greater than 0.05 or less than −0.05) and FDR < 0.05 was applied. We used R software (version 3.2.0) to perform 
these analyzes.
Gene expression array analysis and data processing. Total RNA was extracted and purified from 
whole blood using phenol-chloroform extraction method modified by Chomczynski & Sacchi41. Extracted RNA 
was stored at −80 °C until the next steps. After, RNA integrity number (RIN) was analyzed using Bioanalyzer 
(Agilent Technologies, Cedar Creek, TX, USA). Expression levels were measured using the HumanHT-12 
v4 Expression BeadChip (Illumina Inc.) Expression data were visualized and analyzed using Genome Studio 
Software (Illumina®). Beadchips were also scanned with the Illumina HiScanSQ system and Genome Studio 
Software (Illumina®) was also used. For quality control and normalization, the samples with less than 6000 sig-
nificantly detected probes (detection p-value < 0.01) were excluded and differentially expressed transcripts were 
identified with 95% confidence of no more than 1% false positive using an Mann-Whitney test. A cutoff of p ≤ 
0.05 was used to detect differentially expressed probes. In addition, a cutoff of fold change ≥2.0 (symmetrical fold 
change ≥2.0 or ≤ −2.0) was used. p values obtained from permutations and fold change cutoff values were then 
used to minimize the chances of false positives. Gene expression microarray results were validated using real-time 
polymerase chain reaction (RT-PCR; Applied Biosystems Gene Expression Assays; Applied Biosystems, Foster 
City, CA, USA)20.
For both methylation and expression analysis, samples from obese and normal weight women were randomly 
scattered on each Beadchip and not one batch was one and the other was opposite.
overlapping of pooled gene expression and DnA methylation analysis. Before comparing 
gene expression and methylation analysis, a correction by cellular type was made in DNA methylation data 
(Supplementary Table 1). By crossing and comparing the differentially regulated gene (DEG) and differentially 
methylated genes (DMG), the list generated from the gene expression analysis21 were overlapped with the lists 
from the methylation analysis20 using Venn diagram (http://bioinfogp.cnb.csic.es/tools/venny/). Figure 2 shows a 
schematic diagram of integrative analysis of methylation and expression arrays.
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pathway enrichment analysis. Overrepresented pathways were then obtained from this new list of 
common genes. Genes were classified according to gene function. For this, the WebGestalt program (Gene SeT 
AnaLysis based on the WEB, http://www.webgestalt.org) and KEGG signaling pathway analysis were used. The 
identification numbers (IDs) were loaded and analyzed against the human reference genome by means of a 
Bonferroni multiple test adaptation threshold of p < 0.05.
ethics approval and consent to participate. This study has been approved by the Ethical Committee 
of Clinical Hospital of Ribeirao Preto School of Medicine, University of São Paulo. All patients gave their written 
consent for participation in the study.
Data availability
Illumina HumanHT-12 v4 Expression BeadChip data has been submitted to Gene Expression Omnibus (GEO) 
with accession number GS E83223 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE83223).
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